Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade.
Li Q, Wang Y, Jia W, Deng H, Li G, Deng W, Chen J, Kim BYS, Jiang W, Liu Q, Liu J.
Li Q, et al. Among authors: jia w.
Clin Cancer Res. 2020 Apr 1;26(7):1712-1724. doi: 10.1158/1078-0432.CCR-19-2179. Epub 2019 Dec 17.
Clin Cancer Res. 2020.
PMID: 31848190
Clinical Trial.